ARCHIVES

FDA Committee to Discuss Policy On Combinations

This article is from The Cancer Letter archive.

Vol. 03 No. 01 | January 7, 1977

Download PDF Visit The Full Archive

Related Articles

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

In Brief: David Johnson New ACCC President, William Dugan Named President Elect; Straus Resigns From NYMC

March 12, 1982

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

Trials Approved by NCI CTEP For the Month of May

May 25, 2012